IP Library Granted Patent US 7,122,200
Granted Patent B2
US 7,122,200 · App. 10/013,270 · Granted Oct 17, 2006

Vitro engineered, regenerated urinary tract tissue compositions and methods for producing same

Assignee: The Board of Regents of the University of Oklahoma
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,122,200
App. No.
10/013,270
Granted
Oct 17, 2006
Kind
B2
Abstract

A method for providing a urinary tract tissue graft composition includes providing a tissue culture frame and a segment of small intestinal submucosa and positioning the segment of small intestinal submucosa in the tissue culture frame such that the segment of small intestinal submucosa is suspended and held in a taut position by the tissue culture frame. Smooth muscle and urothelial cells are isolated from a tissue specimen of a subject and cultured, and then seeded upon the segment of small intestinal submucosa, thereby forming a urinary tract tissue graft. A tissue culture frame in which such a urinary tract tissue graft may be formed is also disclosed.

Claims (40)

1. A method for providing a urinary tract tissue graft composition, comprising:

providing a tissue culture frame;

providing a segment of small intestinal submucosa having a mucosal surface and a serosal surface;

positioning the segment of small intestinal submucosa in the tissue culture frame such that the segment of small intestinal submucosa is suspended and held in a taut position by the tissue culture frame;

isolating and culturing at least one cell type from a tissue specimen of a subject; and

seeding the at least one cell type on the segment of small intestinal submucosa.

2. The method of claim 1 wherein, in the step of isolating and culturing at least one cell type from a tissue specimen of a subject, the at least one cell type is selected from the group consisting of smooth muscle cells and urothelial cells.

3. The method of claim 1 further comprising the step of allowing the at least one cell type seeded on the segment of small intestinal submucosa to mature in culture such that the at least one cell type exhibits three dimensional growth and matrix penetrance.

4. A method for providing a urinary tract tissue graft composition, comprising:

providing a tissue culture frame;

providing a segment of small intestinal submucosa having a mucosal surface and a serosal surface;

positioning the segment of small intestinal submucosa in the tissue culture frame such that the segment of small intestinal submucosa is suspended and held in a taut position by the tissue culture frame;

isolating and culturing smooth muscle cells from a tissue specimen of a subject;

isolating and culturing urothelial cells from a tissue specimen of a subject;

seeding the smooth muscle cells on the segment of small intestinal submucosa; and

seeding the urothelial cells on the segment of small intestinal submucosa.

5. The method of claim 4 further comprising the step of allowing the smooth muscle cells and urothelial cells seeded on the segment of small intestinal submucosa to mature in culture such that the smooth muscle cells and urothelial cells exhibit three dimensional growth and matrix penetrance.

6. The method of claim 4 wherein, in the steps of isolating and culturing smooth muscle cells from a tissue specimen of a subject and isolating and culturing urothelial cells from a tissue specimen of a subject, the tissue specimen is bladder tissue, and the smooth muscle cells are bladder smooth muscle cells and the urothelial cells are bladder urothelial cells.

7. The method of claim 4 wherein, in the step of seeding the smooth muscle cells on the segment of small intestinal submucosa, the smooth muscle cells are seeded on the mucosal surface of the segment of small intestinal submucosa.

8. The method of claim 7 wherein, in the step of seeding the urothelial cells on the segment of small intestinal submucosa, the urothelial cells are seeded on the serosal surface of the segment of small intestinal submucosa.

9. The method of claim 7 wherein, in the step of seeding the urothelial cells on the segment of small intestinal submucosa, the urothelial cells are seeded on the smooth muscle cells attached to the mucosal surface of the segment of small intestinal submucosa.

10. The method of claim 4 wherein, in the step of providing the tissue culture frame, the tissue culture frame is formed of a polymer.

11. A method for providing a urinary tract tissue graft composition, comprising:

providing a tissue culture frame;

providing a segment of small intestinal submucosa having a mucosal surface and a serosal surface;

positioning the segment of small intestinal submucosa in the tissue culture frame such that the segment of small intestinal submucosa is suspended and held in a taut position by the tissue culture frame;

isolating and culturing bladder smooth muscle cells from a bladder tissue specimen of a subject;

isolating and culturing bladder urothelial cells from a bladder tissue specimen of a subject;

seeding the bladder smooth muscle cells on the mucosal surface of the segment of small intestinal submucosa; and

seeding the bladder urothelial cells on the serosal surface of the segment of small intestinal submucosa.

12. The method of claim 11 further comprising the step of allowing the bladder smooth muscle cells and bladder urothelial cells seeded on the segment of small intestinal submucosa to mature in culture such that the bladder smooth muscle cells and bladder urothelial cells exhibit three dimensional growth and matrix penetrance.

13. A method for providing a urinary tract tissue graft composition, comprising:

providing a tissue culture frame;

providing a segment of small intestinal submucosa having a mucosal surface and a serosal surface;

positioning the segment of small intestinal submucosa in the tissue culture frame such that the segment of small intestinal submucosa is suspended and held in a taut position by the tissue culture frame;

isolating and culturing bladder smooth muscle cells from a bladder tissue specimen of a subject;

isolating and culturing bladder urothelial cells from a bladder tissue specimen of a subject;

seeding the bladder smooth muscle cells on the mucosal surface of the segment of small intestinal submucosa; and

seeding the bladder urothelial cells on the bladder smooth muscle cells attached to the mucosal surface of the segment of small intestinal submucosa.

14. The method of claim 13 further comprising the step of allowing the bladder smooth muscle cells and bladder urothelial cells seeded on the segment of small intestinal submucosa to mature in culture such that the bladder smooth muscle cells and bladder urothelial cells exhibit three dimensional growth and matrix penetrance.

Assignments (2)
CONFIRMATORY LICENSE Recorded Aug 17, 2010
From: UNIVERSITY OF ILLINOIS URBANA-CHAMPAIGN
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 024838/0470 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 20, 2005
From: KROPP, M.D., BRADLEY; CHENG, M.D., EARL Y.; ZHANG, YUAN YUAN; COWAN, RICK; MOORE, PETER
To: BOARD OF REGENTS OF THE UNIVERSITY OF OKLAHOMA, THE
Reel/Frame 016540/0036 →
Continuity (2)
Provisional Application 6025418600 · Dec 8, 2000
Related Publication 20020087214A1 · Jul 4, 2002